Dr. Tiberio is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1000 Dutch Ridge Rd
Beaver, PA 15009Phone+1 724-773-6405
Summary
- My career path has been anything but linear. I have always had an interest in HIV/AIDS, gay men's health and addiction medicine. My love of critical care medicine and physiology however drew me towards a fellowship in Pulmonary and Critical Care Medicine at UPMC. I am interested in researching ICU outcomes in marginalized populations.
Education & Training
- Yale-New Haven Medical CenterResidency, Internal Medicine, 2014
- State University of New York Downstate Medical Center College of MedicineClass of 2014
Certifications & Licensure
- PA State Medical License 2020 - 2024
- NY State Medical License 2017 - 2020
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- Recipient of Annual Research Day Award/Scholarship SUNY Downstate Medical Center, 2011
- Member American Society of Virologists, 2010
- Travel Grant ASV Conference, 2010
Publications & Presentations
PubMed
- 2 citationsAgitation is a Common Barrier to Recovery of ICU Patients.Niall T Prendergast, Chukwudi A Onyemekwu, Kelly M Potter, Perry J Tiberio, Alison E Turnbull
Journal of Intensive Care Medicine. 2023-02-01 - 1 citationsPharmacologic Management of Delirium in the Intensive Care Unit.Perry J Tiberio, Niall T Prendergast, Timothy D Girard
Clinics in Chest Medicine. 2022-09-01 - 9 citationsTreatment of Delirium During Critical Illness.Niall T Prendergast, Perry J. Tiberio, Timothy D. Girard
Annual Review of Medicine. 2022-01-27
Abstracts/Posters
- ENVolution: Immunoselection of recombinant Vesicular Stomatitis Virus expressing HIV-1 HIV Envelope glycoproteins using broadly neutralizing antibodiesTiberio, PJ, AIDS Vaccine 2011, Bangkok, Thailand
- ENVolution: Immunoselection of recombinant Vesicular Stomatitis Virus expressing HIV-1 HIV Envelope glycoproteins using broadly neutralizing antibodiesTiberio and PJ, ASV 2009, Montana
Research History
- Graduate StudentPhD thesis focused on developing novel HIV Envelope glycoprotein immunogens using recombinant Vesicular stomatitis virus. Research was performed at the International AIDS Vaccine Initiative (IAVI) Design and Development Laboratory in Brooklyn, NY.2008 - 2012
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: